Victory Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $8.99M | Sell |
|
|||||
|
2025
Q2 | $15.1M | Buy |
|
|||||
|
2025
Q1 | $378K | Buy |
|
|||||
|
2024
Q4 | $434K | Sell |
|
|||||
|
2024
Q3 | $608K | Buy |
|
|||||
|
2024
Q2 | $414K | Sell |
|
|||||
|
2024
Q1 | $474K | Sell |
|
|||||
|
2023
Q4 | $505K | Buy |
|
|||||
|
2023
Q3 | $260K | Buy |
|
|||||
|
2023
Q2 | $330K | Sell |
|
|||||
|
2023
Q1 | $293K | Sell |
|
|||||
|
2022
Q4 | $342K | Sell |
|
|||||
|
2022
Q3 | $306K | Sell |
|
|||||
|
2022
Q2 | $446K | Buy |
|
|||||
|
2022
Q1 | $527K | Buy |
|
|||||
|
2021
Q4 | $625K | Buy |
|
|||||
|
2021
Q3 | $597K | Buy |
|
|||||
|
2021
Q2 | $588K | Sell |
|
|||||
|
2021
Q1 | $731K | Sell |
|
|||||
|
2020
Q4 | $936K | Buy |
|
|||||
|
2020
Q3 | $388K | Sell |
|
|||||
|
2020
Q2 | $393K | Sell |
|
|||||
|
2020
Q1 | $472K | Buy |
|
|||||
|
2019
Q4 | $316K | Buy |
|
|||||
|
2019
Q3 | $270K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $39K | Buy |
|
|||||
|
2018
Q2 | $34K | Hold |
|
|||||
|
2018
Q1 | $23K | Hold |
|
|||||
|
2017
Q4 | $21K | Hold |
|
|||||
|
2017
Q3 | $24K | Hold |
|
|||||
|
2017
Q2 | $28K | Buy |
|
|||||
|
2017
Q1 | $27K | Buy |
|
|||||
|
2016
Q4 | $23K | Buy |
|
|||||
|
2016
Q3 | $21K | Buy |
|